title: The effect of combination therapy on regression of left ventricular hypertrophy in cases with hypertension.
abstract: OBJECTIVE
  Up to this date, it is well shown that several antihypertensive drugs have different regressive effect on left ventricular hypertrophy (LVH). However, there are different studies regarding the effect of antihypertensive combination therapies on regression of LVH. In this study, 2 different combinations ACE-I plus calcium channel blocker and ACE-I plus diuretic were compared in cases with hypertension whose BPs were not controlled by ACE-I alone.
  
  
  METHODS
  Forty patients with mild to moderate hypertension were included in this study. The treatment was continued for 6 months in the Faculty of Medicine at Ege University, Turkey, between January and December 2003. Adequate response with lisinopril 20 mg/daily failed to be achieved in all patients. Patients divided into 2 groups. There were no differences between the groups in patients' age, blood pressure (BP) and other clinical and laboratory range. First group patients received lisinopril 20 mg + nifedipine GITS 30 mg and second group patients received lisinopril 20 mg + hydrochlorothiazide 25 mg. The treatment was continued for 6 months. Blood pressure were measured every 2 weeks, echocardiographic findings, and blood and urinary analysis were performed before and at the end of treatment.
  
  
  RESULTS
  Systolic and diastolic BP decreased significantly in both groups and no significant difference regarding BP was found between the 2 groups. Left ventricular mass index also decreased significantly in both groups. However, in the first group left ventricular mass index decreased more compared to the second group.
  
  
  CONCLUSIONS
  The effect of combination therapies with angiotensin converting enzyme inhibitor (ACE-I) plus diuretic and ACE-I plus calcium channel blocker on systolic and diastolic BP are similar. However, when LVH is present, regressive effect of the combination of ACE-I plus calcium channel blocker is superior to the combination of ACE-I plus diuretic.
authors.affiliation: Department of Emergency Cardiology, Faculty of Medicine, Ege University, 1780/2 sokak, No. 9 D. 1, 35530 Karsiyaka, Izmir, Turkey. boydak@med.ege.edu.tr
authors.forename: Bahar
authors.initials: B
authors.lastname: Boydak
authors.forename: Sanem
authors.initials: S
authors.lastname: Nalbantgil
authors.forename: Hasan
authors.initials: H
authors.lastname: Yilmaz
authors.forename: Mehdi
authors.initials: M
authors.lastname: Zoghi
authors.forename: Filiz
authors.initials: F
authors.lastname: Ozerkan
authors.forename: Istemi
authors.initials: I
authors.lastname: Nalbantgil
authors.forename: Remzi
authors.initials: R
authors.lastname: Onder
mesh_terms: D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002306:Cardiac Volume / Q000187:drug effects; D004359:Drug Therapy, Combination; D004452:Echocardiography / Q000187:drug effects; D006352:Heart Ventricles / Q000000981:diagnostic imaging / Q000187:drug effects; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use*; D006973:Hypertension / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D017379:Hypertrophy, Left Ventricular / Q000000981:diagnostic imaging / Q000188:drug therapy*; D017706:Lisinopril / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009543:Nifedipine / Q000627:therapeutic use*; D020257:Ventricular Remodeling / Q000187:drug effects*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D006852:Hydrochlorothiazide; D017706:Lisinopril; D009543:Nifedipine